Moreover, the ‘HPV‐related CA cluster’ specifically expressed CALML5, which is closely associated with recurrence and survival outcomes in patients with HPV‐related cancers such as head‐and‐neck carcinoma and oropharyngeal cancer. Here, CALML5 is linked to oropharynx cancer.